Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 6Terminated 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2CNS 1

Conditions

Neoplasm Metastasis 10Carcinoma, Non-Small-Cell Lung 10Breast Neoplasms 9Lung Neoplasms 5Prostatic Neoplasms 4Pancreatic Neoplasms 4Neoplasms 4Leukemia, Myeloid, Acute 4Colorectal Neoplasms 4Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Melanoma 3Leukemia 3Glioblastoma 3Cholangiocarcinoma 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Recurrence 2Gliosarcoma 2Glioma 2Congenital Abnormalities 2Colonic Neoplasms 2Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Thrombocythemia, Essential 1Stomatitis 1Primary Myelofibrosis 1Polycythemia Vera 1Pleural Effusion, Malignant 1Pain 1

Interventions

Temozolomide 19Radiotherapy 11Bevacizumab 7Radiation 4Irinotecan 4Erlotinib Hydrochloride 4carmustine, poliferprosan 20 drug combination 3Radiotherapy, Intensity-Modulated 3O(6)-benzylguanine 3Magnetic Resonance Spectroscopy 3Carmustine 32,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 3Vorinostat 2Surgical Procedures, Operative 2Radiotherapy, Conformal 2Radiosurgery 2Gadolinium DTPA 2Filgrastim 2Drug Therapy 2Congresses as Topic 2Cilengitide 2Chemotherapy, Adjuvant 2Aminolevulinic Acid 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vitespin 1sargramostim 1sapanisertib 1poly ICLC 1plerixafor 1picropodophyllin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Gliosarcoma × Drug Therapy × Clear all
NCT01822275 2022-12-29

GCC 1224

University of Maryland, Baltimore

Phase 2 Terminated
24 enrolled 9 charts
Sarcoma

Gliosarcoma

NCT00238277 2018-06-27

Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
15 enrolled
CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡